6468 Journal of Medicinal Chemistry, 2008, Vol. 51, No. 20
Liang et al.
and tris(tetra-n-butylammonium) hydrogen methylene pyrophos-
phate (472 mg, 0.53 mmol). Compound 9 (74 mg (55%) was
obtained as a white fluffy solid. HPLC RT 59.7 min (program A).
1H NMR (D2O) δ 7.85 (1H, d, J ) 7.8 Hz, H6), 6.19 (1H, t, J )
6.5 Hz, H1′), 5.98 (1H, d, J ) 7.6 Hz, H5), 4.47 (1H, m, H3′),
4.03 (1H, m, H4′), 3.99 (2H, m, H5′,H5′′), 2.25-2.35 (2H, m,
H2′,H2′′), 1.99 (2H, t, J ) 19.6 Hz, PR-CΗ2-Pꢀ). 31P NMR (D2O)
δ 19.92 (m, PR), 16.54 (m, Pꢀ). LR-MS (ESI) (M + H)+ 386.29.
r,ꢀ-Methylene 2′-Deoxyguanosine 5′-Diphosphate (11) and 3,5′-
cyclo-2′-Deoxyguanosine (16). The coupling reaction between 4 (147
mg, 0.35 mmol) and tris(tetra-n-butylammonium) hydrogen methy-
lene pyrophosphate (472 mg, 0.53 mmol) gave two main fractions
with an approximately equal intensity after an FPLC. An early
eluting major fraction was collected and purified by HPLC to afford
3,5′-cyclo-2′-deoxyguanosine (cyclo-dG, 16) (14 mg, 16%) as a
Final purification of the triphosphate product was performed on
FPLC with a Q Sepharose FF anion exchange column (2.5 cm ×
-
20 cm, HCO3 form) by a linear gradient elution with NH4HCO3
(from 0.05 to 0.5 M, pH 7.8) at a flow rate of 2 mL/min monitored
at 230 nm. The desired fractions were pooled and lyophilized to
+
give a white fluffy solid 12 (25 mg, NH4 salt, 52%). HPLC RT
1
89.3 min (program A). H NMR (D2O) δ 8.37 (1H, s, H8), 8.10
(1H, dd, J ) 6.6 Hz, H2), 6.35 (1H, t, J ) 6.6 Hz, H1′), 4.70 (1H,
m, H3′), 4.13 (1H, s, H4′), 3.97 (2H, m, H5′), 2.71-2.44 (1H, m,
H2′, H2′′), 2.20 (2H, t, J ) 20.3 Hz, PR-CΗ2-Pꢀ). 31P NMR (D2O)
δ 23.33 (m, PR), 12.42 (m, Pꢀ) -4.82 (d, JP-P ) 24.7 Hz, Pγ).
HRMS (ESI): calcd, 488.0137 (M - H)-; found, 488.0143 (M -
H)-.
r,ꢀ-methylene-dCTP (13). Compound 13 was prepared in a
similar manner to 12 from 9 (30 mg, 0.08 mmol) to yield 18 mg
(NH4+ salt, 49%) of 13 as a white fluffy solid. HPLC RT 69.1 min.
1H NMR (D2O) δ 7.83 (1H, d, J ) 7.8 Hz, H6), 6.18 (1H, m, J )
6.1 Hz, H1′), 5.96 (1H, d, J ) 7.8, H5) 4.48 (1H, m, H3′), 4.04
(1H, m, H4′), 3.96 (2H, m, H5′,H5′′), 2.15-2.32 (2H, m, H2′,H2′′),
2.24 (2H, t, J ) 20.4 Hz, PR-CΗ2-Pꢀ). 31P NMR (D2O) δ 23.29
(m, PR), 12.27 (m, Pꢀ), -4.87 (d, JP-P ) 25.8 Hz, Pγ). HRMS
(ESI): calcd, 464.0025 (M - H)-; found, 464.0032 (M - H)-.
r,ꢀ-Methylene-dTTP (14). Compound 14 was prepared from 10
1
white fluffy solid. 16: H NMR (DMSO-d6) δ 7.64 (1H, s, H8),
7.04 (2H, bs, NH2), 6.50 (1H, dd, J ) 5.2 Hz, H1′), 5.53, (1H, bs,
3′-OH), 4.54 (1H, m, H4′), 4.50 (1H, d, J ) 13.6 Hz, H5′), 4.40
(1H, m, H3′), 3.84 (1H, d, J ) 13.6 Hz, H5′′), 2.16 (2H, m,
H2′,H2′′). 13C NMR (D2O): 89.15 (C1′), 84.39 (C4′), 70.50 (C3′),
53.80 (C5′), 42.97 (C2′). LR-MS (ESI) [M + H]+ 250.13. HRMS
(ESI): calcd, 250.0935 (M + H)+; found, 250.0925 (M + H)+.
The late eluting fractions were identified as the desired diphosphate
product 11 (44 mg, 30%) as a white fluffy solid. 11: HPLC RT
+
(25 mg 0.06 mmol) as described above to yieled 13 mg (NH4
1
salt, 45%) of 14 as a white fluffy solid. HPLC RT 82.5 min (program
A). 1H NMR (D2O) δ 7.72 (1H, s, H6), 6.31 (1H, dd, J ) 6.8 Hz,
H1′), 4.61 (1H, m, H3′), 4.2 - 4.1 (3H, m, H4′, H5′,H5′′), 2.37
(2H, m, H2′, H2′′), 2.34 (2H, t, J ) 20.4 Hz, PR-CΗ2-Pꢀ), 1.90
(3H, s, CH3). 31P NMR (D2O) δ 21.82 (m, PR), 11.42 (m, Pꢀ),
-6.04 (d, JP-P ) 16.7 Hz, Pγ). HRMS (ESI): calcd, 479.0022 (M
- H)-; found, 479.0028 (M - H)-.
61.8 min (program A). H NMR (D2O) δ 8.28 (1H, s, H8), 6.32
(1H, t, J ) 6.9 Hz, H1′), 4.72 (1H, m, H3′), 4.25 (1H, m, H4′),
4.10 (2H, m, H5′), 2.80-2.52 (2H, m, H2′,H2′); 2.13 (2H, t, J )
19.8 Hz, PR-CΗ2-Pꢀ). 31P NMR (D2O) δ 19.47 (m, PR), 16.08
(m, Pꢀ). LR-MS (ESI) (M + H)+ 425.83.
r,ꢀ-methylene 2′-deoxythymidine 5′-diphosphate (10) and 2,5′-
cyclo-2′-Deoxythymidine (17). The usual coupling reaction of 3 (100
mg, 0.25 mmol) with tris(tetra-n-butylammonium) hydrogen me-
thylene pyrophosphate (340 mg, 0.38 mmol) gave two main
fractions of equal abundance by FPLC. An early eluting major
fraction was collected and purified by HPLC to give 2,5′-cyclo-dT
r,ꢀ-methylene-dGTP (15). Compound 15 was prepared from 11
+
(30 mg 0.08 mmol) to give 21 mg (NH4 salt, 52%) of 15 as a
white fluffy solid. 15: HPLC RT 69.4 min. 1H NMR (D2O) δ 8.47
(1H, s, H8), 6.31 (1H, t, J ) 6.5 Hz, H1′), 4.84 (1H, m, H3′), 4.23
(1H, m, H4′), 4.15 (2H, m, H5′,H5′′), 2.85-2.50 (2H, m, H2′,H2′′),
2.32 (2H, t, J ) 19.8 Hz, PR-CH2-Pꢀ). 31P NMR (D2O) δ 22.19
(m, PR), 11.37 (m, Pꢀ), -6.07 (t, JP-P ) 23.8 Hz, Pγ). HRMS
(ESI): calcd, 504.0087 (M - H)-; found 504.0092 (M - H)-.
Alternative Synthesis of Cyclo-dG (16) and Cyclo-dT (17).
Cyclo-dG (16) was prepared according to a modified literature
procedure.35,36 A solution of DIAD (690 mg, 3 mmol) in dioxane
(1.0 mL) was added dropwise to a suspension of dG (268 mg, 1.0
mmol) and triphenyl phosphine (786 mg, 3.0 mmol) in dioxane
(2.0 mL) at 70 °C. dG was solubilized as DIAD was added. The
resulting homogeneous solution was stirred at 70 °C for 3 h and
then allowed to cool to ambient temperature. The resulting
precipitate was filtered and washed with dioxane. Purification by
silica gel column chromatography (ethyl acetate:methanol 60:40)
gave 16 (80 mg, 30%). The chromatographic (TLC, HPLC) and
spectroscopic (1H NMR, UV, CD, ESI-HRMS) properties of this
sample match to those obtained from the coupling reaction between
5′-O-tosyl-2′-dG 4 and methylene diphosphate described above.
Cyclo-dT (17) was prepared according to a general cyclization
procedure.24 To a solution of 3 (1.13 g, 2.54 mmol) in acetonitrile
(70 mL) was added DBU (0.7 g, 4.6 mmol). The reaction mixture
was refluxed for 1 h and was monitored for starting material by
TLC (CH2Cl2-CH3OH (80:20)). After 90 min, TLC indicated the
reaction was complete. The hot solution was immediately filtered
through a celite pad, and the filtrate was evaporated to dryness.
The residue was purified by silica gel column chromatography
(CH2Cl2-CH3OH (80:20)) to give 285 mg (50%) of pure 17. The
chromatographic (TLC, HPLC) and spectroscopic (1H NMR, UV,
CD, ESI-HRMS) properties of this sample match to those obtained
from the coupling reaction between 3 and methylene diphosphate
described above.
1
17 (cyclo-dT; 167 mg, 31%). H NMR (D2O) δ 7.75 (1H, s, H6),
6.1 (1H, dd, J ) 8.0, 1.8 Hz, H1′), 4.82 (1H, m, H4′), 4.62 (1H, d,
J ) 12.9 Hz, H5′), 4.55 (1H, m, H3′), 4.26 (1H, d, J ) 12.9 Hz,
H5′′), 2.67 (1H, m, H2′), 2.49 (1H, m, H2′′), 1.92 (3H, s, CH3).
13C NMR (DMSO-d6) δ 171.90 (C4), 158.09 (C2), 141.42 (C6),
118.69 (C5), 94.64 (C1′), 86.34 (C4′), 75.36 (C5′), 71.96 (C3′),
41.95 (C2′), 12.36 (CH3). LR-MS (ESI) (M + H)+ 225.07. HRMS
(ESI): calcd, 225.0870 (M + H)+; found, 225.0859 (M + H)+.
The late eluting fractions were identified as the desired diphosphate
product 10 (30 mg, 30%) as a white fluffy solid. HPLC RT 45.4
1
min (program). H NMR (D2O) δ 7.60 (1H, s, H6), 6.19 (1H, dd,
J ) 6.7 Hz, H1′), 4.48 (1H, m, H3′), 4.03 (1H, m, H4′), 3.98 (2H,
m, H5′,H5′′), 2.15-2.45 (2H, m, H2′,H2′′), 2.03 (2H, t, J ) 19.8
Hz, PR-CΗ2-Pꢀ), 1.78 (3H, s, CH3). 31P NMR (D2O) δ 19.90 (m,
PR), 16.45 (m, Pꢀ). LR-MS (ESI) (M + H)+ 400.99.
Synthesis of r,ꢀ-Methylene 2′-Deoxynucleoside 5′-Triphos-
phate (r,ꢀ-m-dNTP; 12-15). r,ꢀ-methylene-dATP (12). A mixture
of 8 (40 mg, 0.1 mmol), ATP (55 mg, 0.1 mmol), and phosphoenol
pyruvate (PEP, 38 mg, 0.2 mmol) were placed in a 10 mL solution
of triethanolamine (83 mM), MgCl2 (17 mM), KCl (67 mM). The
pH of the mixture was adjusted to 7.6 with 6.0 M NaOH.
Nucleoside diphosphate kinase (NDPK) (200 unit) and pyruvate
kinase (400 unit) were added to this solution, and the mixture was
incubated at 37 °C for 4 h. The reaction progress was monitored
by HPLC (program A) until γ-phosphorylation was complete. Then
ADP (45 mg, 0.1 mmol) was added to remove the excess PEP in
the reaction mixture. After 1 h, the mixture was filtered through a
0.2 µm syringe disk and lyophilized. The residual solid on the disk
was dissolved in 10 mL of 1 M NH4HCO3 and adjusted to pH 8.5
with concentrated NH4OH. The mixture was then applied to a Bio-
Rad boronate affinity gel column (2.5 cm × 5.5 cm, in 1 M
NH4HCO3, pH 8.5). The column was eluted with the same buffer
at a flow of 1 mL/min and the fractions containing the first two-
column volumes were pooled and lyophilized. Excess NH4HCO3
was removed by repeated lyophilization from deionized water after
adjustment to pH 7.2 with CO2.
Stability Studies of 2′-Cyclonucleosides. General Procedure.
Cyclonucleosides (0.2 mmol) were placed in 5.0 mL of either 1.0
M HCl or 1.0 M NaOH for acid and base hydrolysis, respectively.
Reaction progress at either 37 or 100 °C was monitored by HPLC/
UV using gradient program B. After appropriate time, the reaction